These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 12883268)

  • 41. Novel patient-derived xenograft mouse model for pancreatic acinar cell carcinoma demonstrates single agent activity of oxaliplatin.
    Hall JC; Marlow LA; Mathias AC; Dawson LK; Durham WF; Meshaw KA; Mullin RJ; Synnott AJ; Small DL; Krishna M; von Hoff D; Schüler J; Hart SN; Couch FJ; Colon-Otero G; Copland JA
    J Transl Med; 2016 May; 14(1):129. PubMed ID: 27165126
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Dehydroepiandrosterone-sulfate inhibits pancreatic carcinoma cell proliferation in vitro and in vivo.
    Melvin WS; Boros LG; Muscarella P; Brandes JL; Johnson JA; Fisher WE; Schirmer WJ; Ellison EC
    Surgery; 1997 Apr; 121(4):392-7. PubMed ID: 9122868
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Gene therapy for pancreatic cancer using an adenovirus vector encoding soluble flt-1 vascular endothelial growth factor receptor.
    Hoshida T; Sunamura M; Duda DG; Egawa S; Miyazaki S; Shineha R; Hamada H; Ohtani H; Satomi S; Matsuno S
    Pancreas; 2002 Aug; 25(2):111-21. PubMed ID: 12142732
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Triptolide induces pancreatic cancer cell death via inhibition of heat shock protein 70.
    Phillips PA; Dudeja V; McCarroll JA; Borja-Cacho D; Dawra RK; Grizzle WE; Vickers SM; Saluja AK
    Cancer Res; 2007 Oct; 67(19):9407-16. PubMed ID: 17909050
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The oral multitarget tumour growth inhibitor, ZK 304709, inhibits growth of pancreatic neuroendocrine tumours in an orthotopic mouse model.
    Scholz A; Wagner K; Welzel M; Remlinger F; Wiedenmann B; Siemeister G; Rosewicz S; Detjen KM
    Gut; 2009 Feb; 58(2):261-70. PubMed ID: 18829975
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Inhibition effects of octreotide on the growth of hepatocellular carcinoma in vitro and in vivo].
    Wang C; Tang C; Tang L
    Zhonghua Yi Xue Za Zhi; 2001 Oct; 81(19):1194-7. PubMed ID: 11769709
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cytotoxic analog of somatostatin containing methotrexate inhibits growth of MIA PaCa-2 human pancreatic cancer xenografts in nude mice.
    Radulovic S; Nagy A; Szoke B; Schally AV
    Cancer Lett; 1992 Mar; 62(3):263-71. PubMed ID: 1317746
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antiribosomal P protein antibodies in systemic lupus erythematosus. A reappraisal.
    Teh LS; Isenberg DA
    Arthritis Rheum; 1994 Mar; 37(3):307-15. PubMed ID: 8129786
    [No Abstract]   [Full Text] [Related]  

  • 49. Causality between autoimmune diseases and breast cancer: a two-sample Mendelian randomization study in a European population.
    Zhang H; Shen G; Yang P; Wu M; Li J; Li Z; Zhao F; Liang H; Da M; Wang R; Zhang C; Zhao J; Zhao Y
    Discov Oncol; 2024 Sep; 15(1):396. PubMed ID: 39217596
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Beneficial autoimmunity and maladaptive inflammation shape epidemiological links between cancer and immune-inflammatory diseases.
    Pol J; Paillet J; Plantureux C; Kroemer G
    Oncoimmunology; 2022; 11(1):2029299. PubMed ID: 35070497
    [TBL] [Abstract][Full Text] [Related]  

  • 51. S-1 induced discoid lupus erythematosus-like lesions and long-term complete response for para-aortic lymph node recurrence of pancreatic ductal adenocarcinoma: a case report.
    Yamaga R; Tezuka K; Sugawara S; Watanabe T; Hirai I; Suzuki T; Kimura W
    Surg Case Rep; 2018 Jun; 4(1):52. PubMed ID: 29882080
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Biologic effect of neurogenesis in pancreatic cancer.
    He D; Manzoni A; Florentin D; Fisher W; Ding Y; Lee M; Ayala G
    Hum Pathol; 2016 Jun; 52():182-9. PubMed ID: 26980040
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Autoantibody-mediated inhibition of pancreatic cancer cell growth in an athymic (nude) mouse model.
    Gardner-Thorpe J; Ito H; Ashley SW; Whang EE
    Pancreas; 2003 Aug; 27(2):180-9. PubMed ID: 12883268
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Apoptotic activity and antitumor efficacy of PEGylated TNF-related apoptosis-inducing ligand (TRAIL) in a Mia Paca-2 cell-xenografted mouse model.
    Byeon HJ; Choi SH; Choi JS; Kim TH; Lee ES; Lee KC; Youn YS
    Biomed Pharmacother; 2014 Feb; 68(1):65-9. PubMed ID: 24268811
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Leukotriene B4 receptor antagonist LY293111 inhibits proliferation and induces apoptosis in human pancreatic cancer cells.
    Tong WG; Ding XZ; Hennig R; Witt RC; Standop J; Pour PM; Adrian TE
    Clin Cancer Res; 2002 Oct; 8(10):3232-42. PubMed ID: 12374694
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A quinolinone derivative, vesnarinone (OPC-8212), significantly inhibits the in vitro and in vivo growth of human pancreatic cancer cell lines.
    Nio Y; Ohmori H; Minari Y; Hirahara N; Sasaki S; Takamura M; Tamura K
    Anticancer Drugs; 1997 Aug; 8(7):686-95. PubMed ID: 9311445
    [TBL] [Abstract][Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.